Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Supply of Raltegravir 400mg tablets and Raltegravir 600mg tablets (Isentress®) to NHS Scotland.
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| Merck Sharp & Dohme UK Ltd | 00233687 | - | 1 lot Lot 1 | - |
This procurement was divided into 1 lots, each awarded separately. 1 bids were received in total.
| Lot | Value | Bids Received | Awarded To | Status |
|---|---|---|---|---|
| Lot 1 | £2,523,285 initial term | 1 single bid — no competition | Merck Sharp & Dohme UK Ltd | complete |
Weightings from the notice.
Government spending data: This supplier has received £268,617,155 in 38 payments (over £25k) from Department of Health and Social Care, UK Health Security Agency, NHS England (2018-02-28 to 2025-12-09). View full payment history →